December 16, 2016
ABIVAX welcomes Didier Blondel as CFO
ABIVAX has appointed Didier Blondel as Chief Financial Officer, effective January 2nd, 2017.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Didier Blondel
Pharmaceuticals, Biotechnology and Life Sciences
ABIVAX has appointed Didier Blondel as Chief Financial Officer, effective January 2nd, 2017.